Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
Immunogenic polysaccharide-protein conjugates having a polysaccharide antigen (or its oligosaccharide fragment representing one or more antigenic epitopes) derived from a nosocomial pathogen conjugated to a staphylococcal surface adhesin carrier protein are used in immunogenic compositions to elicit antibody responses to both the polysaccharide antigen and the staphylococcal surface adhesion carrier protein. Such immunogenic compositions are used to immunize against diseases caused by Staphylococcal aureus, Staphylococcal epidermidis or other nosocomial pathogens.
1. An immunogenic polysaccharide-protein conjugate, comprising: at least one polysaccharide antigen derived from a nosocomial pathogen and at least one staphylococcal surface adhesin carrier protein,
wherein the conjugate generates specific antibodies to both the polysaccharide antigen and the staphylococcal surface adhesin carrier protein, and
wherein the polysaccharide antigen is an antigen from coagulase-negative staphylococci (CoNS), wherein the CoNS is Staphylococcus epidermidis ( S. epidermidis ).
2. An immunogenic polysaccharide-protein conjugate, comprising: an oligosaccharide fragment representing one or more antigenic epitopes of at least one polysaccharide antigen derived from a nosocomial pathogen and at least one staphylococcal surface adhesin carrier protein,
wherein the conjugate generates specific antibodies to both the polysaccharide antigen and the staphylococcal surface adhesin carrier protein, and
wherein the polysaccharide antigen is an antigen from coagulase-negative staphylococci (CoNS), wherein the CoNS is Staphylococcus epidermidis ( S. epidermidis ).
3. The conjugate of claim 1 , wherein the polysaccharide antigen is polysaccharide intercellular adhesin (PIA), polysaccharide adhesin (PS/A), poly-N-succinyl β-1-6-glucosamine (PNSG), or poly-N-acetyl β-1-6-glucosamine (PNAG), expressed by S. epidermidis.
4. The conjugate of claim 1 , wherein the staphylococcal surface adhesin carrier protein is selected from the group consisting of fibrinogen-binding protein, fibronectin-binding protein, collagen-binding protein, vitronectin-binding protein and combinations thereof.
5. The conjugate of claim 4 , wherein the staphylococcal surface adhesin carrier protein is the fibronectin-binding protein of S. aureus.
6. The conjugate of claim 4 , wherein the staphylococcal surface adhesin carrier protein is the collagen-binding protein of S. aureus.
7. The conjugate of claim 4 , wherein the staphylococcal surface adhesin carrier protein is the vitronectin-binding protein of S. aureus.
8. The conjugate of claim 1 , wherein the polysaccharide antigen is conjugated to the staphylococcal surface adhesin carrier protein through a linker.
9. The conjugate of claim 8 , wherein the linker is 3-(2-pyridyldithio)-propionyl hydrazide (PDPH).
10. An immunogenic composition comprising the conjugate of claim 1 in an immunologically acceptable carrier or diluent.
11. The immunogenic composition of claim 10 , further comprising an adjuvant.
12. The conjugate of claim 2 , wherein the polysaccharide antigen is polysaccharide intercellular adhesin (PIA), polysaccharide adhesin (PS/A), poly-N-succinyl β-1-6-glucosamine (PNSG), or poly-N-acetyl β-1-6-glucosamine (PNAG), expressed by S. epidermidis.
13. The conjugate of claim 2 , wherein the staphylococcal surface adhesin carrier protein is selected from the group consisting of fibrinogen-binding protein, fibronectin-binding protein, collagen-binding protein, vitronectin-binding protein and combinations thereof.
14. The conjugate of claim 13 , wherein the staphylococcal surface adhesin carrier protein is the fibronectin-binding protein of S. aureus.
15. The conjugate of claim 13 , wherein the staphylococcal surface adhesin carrier protein is the collagen-binding protein of S. aureus.
16. The conjugate of claim 13 , wherein the staphylococcal surface adhesin carrier protein is the vitronectin-binding protein of S. aureus.
17. The conjugate of claim 2 , wherein the polysaccharide antigen is conjugated to the staphylococcal surface adhesin carrier protein through a linker.
18. The conjugate of claim 17 , wherein the linker is 3-(2-pyridyldithio)propionyl hydrazide (PDPH).
19. An immunogenic composition comprising the conjugate of claim 2 in an immunologically acceptable carrier or diluent.
20. The immunogenic composition of claim 19 , further comprising an adjuvant.
21. An immunogenic polysaccharide-protein conjugate, comprising: at least one polysaccharide antigen derived from a nosocomial pathogen and at least one staphylococcal surface adhesin carrier protein,
wherein the conjugate generates specific antibodies to both the polysaccharide antigen and the staphylococcal surface adhesin carrier protein, and
wherein the polysaccharide antigen is an antigen from Staphylococcus aureus ( S. aureus ), or coagulase-negative staphylococci (CoNS), wherein the CoNS is Staphylococcus epidermidis ( S. epidermidis ) and
wherein the polysaccharide antigen is polysaccharide intercellular adhesin (PIA), polysaccharide adhesin (PS/A), poly-N-succinyl β-1-6-glucosamine (PNSG), or poly-N-acetyl β-1-6-glucosamine (PNAG), expressed by S. aureus or S. epidermidis.
22. An immunogenic polysaccharide-protein conjugate, comprising: an oligosaccharide fragment representing one or more antigenic epitopes of at least one polysaccharide antigen derived from a nosocomial pathogen and at least one staphylococcal surface adhesin carrier protein,
wherein the conjugate generates specific antibodies to both the polysaccharide antigen and the staphylococcal surface adhesin carrier protein, and
wherein the polysaccharide antigen is an antigen from Staphylococcus aureus ( S. aureus ) or coagulase-negative staphylococci (CoNS), wherein the CoNS is Staphylococcus epidermidis ( S. epidermidis ); and
wherein the polysaccharide antigen is polysaccharide intercellular adhesin (PIA), polysaccharide adhesin (PS/A), poly-N-succinyl β-1-6-glucosamine (PNSG), or poly-N-acetyl β-1-6-glucosamine (PNAG), expressed by S. aureus or S. epidermidis.